Managing and Preparing for Emerging Infectious Diseases: Avoiding a Catastrophe
- 1 November 2020
- journal article
- research article
- Published by Academy of Management in Academy of Management Perspectives
- Vol. 34 (4), 480-492
- https://doi.org/10.5465/amp.2019.0023
Abstract
The extent and impact of neglected diseases has been well documented in the public health and medical science literature. However, from an organizational perspective, there is a gap in understanding the complex relationships that underpin the functioning of Product Development Partnerships (PDPs) in managing the drug development process. This paper focuses on (a) identifying the importance of PDPs in the development of new drugs for neglected and emerging infectious diseases; and (b) identifying the key stakeholders, their relationships and (levels) of dependencies in PDPs through the resource dependency lens. Our model offers a unique perspective to the strategic alliance literature by not only showing the complex interrelationships between various stakeholders but also in highlighting power, trust and governance ask key challenges. Based on our findings, we suggest an agenda for future research that enhances our understanding to mitigate risks related to neglected and emerging infectious diseases from an organizational perspective.Keywords
This publication has 48 references indexed in Scilit:
- The Two Facets of Collaboration: Cooperation and Coordination in Strategic AlliancesAcademy of Management Annals, 2012
- Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIVCell, 2012
- A Systematic Review of Collaboration and Network Research in the Public Affairs Literature: Implications for Public Health Practice and ResearchAmerican Journal of Public Health, 2012
- Challenges of Antibacterial DiscoveryClinical Microbiology Reviews, 2011
- Neglected Disease Research and Development: How Much Are We Really Spending?PLoS Medicine, 2009
- Challenges facing drug development for malariaCurrent Opinion in Microbiology, 2008
- A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We NeedPLoS Medicine, 2005
- Drug development for neglected diseases: a deficient market and a public-health policy failureThe Lancet, 2002
- Between Trust and Control: Developing Confidence in Partner Cooperation in AlliancesAcademy of Management Review, 1998
- Not So Different After All: A Cross-Discipline View Of TrustAcademy of Management Review, 1998